| dc.contributor.author | Muñoz, Montserrat | |
| dc.contributor.author | Estévez, Laura G. | |
| dc.contributor.author | Álvarez, Isabel | |
| dc.contributor.author | Fernández Pérez, Yolanda | |
| dc.contributor.author | Margelí, Mireia | |
| dc.contributor.author | Tusquets, Ángel | |
| dc.contributor.author | Seguí, Miguel | |
| dc.contributor.author | Lluch Bernal, Ana | |
| dc.date.accessioned | 2014-03-14T07:41:03Z | |
| dc.date.available | 2014-03-14T07:41:03Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Cancer Treatment Reviews, 34(8), p. 701-709 (2008); doi:10.1016/j.ctrv.2008.04.002 | |
| dc.identifier.issn | 0305-7372 | |
| dc.identifier.uri | http://hdl.handle.net/10651/23720 | |
| dc.description.sponsorship | The authors acknowledge the support of GlaxoSmithKline Spain, which has supported the necessary meetings to evaluate and discuss all the data presented in this review, and Dr. Beatriz Gil-Alberdi from HealthCo SL for her assistance in the preparation of this manuscript | |
| dc.format.extent | p. 701-709 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cancer Treatment Reviews | |
| dc.rights | © 2008 Published by Elsevier Ltd | |
| dc.source | WOS | |
| dc.title | Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer | |
| dc.type | journal article | |
| dc.identifier.local | 20140616 | |
| dc.identifier.doi | 10.1016/j.ctrv.2008.04.002 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1016/j.ctrv.2008.04.002 | |
